http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101821277-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-323
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
filingDate 2008-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_355a10a8b18a058020bb88dd04f50c89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7842477ed54bc2047e8763331de6c21e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e6f4065e850677ff3ccec0b63963dfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_483f18a65e4437037e161924ee008f81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdeb347610ee450a536df18a9396c312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01b9147ed526c48e662da7913250dbfd
publicationDate 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101821277-B
titleOfInvention tetrahydropyran nucleic acid analogs
abstract Tetrahydropyranucleoside analogs, oligomeric compounds prepared therefrom, and methods of using the oligomeric compounds are described. More specifically, tetrahydropyranucleoside analogs having one or more chiral substituents are provided that are useful for enhancing properties of oligomeric compounds, including nuclease resistance and binding affinity. In some embodiments, an oligomeric compound provided herein hybridizes to a portion of a target RNA such that the target RNA loses normal function.
priorityDate 2007-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466371036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467113952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467439478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466883832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466883860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466518635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467687823

Total number of triples: 37.